Live Chart

O 0

H 0

L 0

VOL 0

Aspira Pathlab & Diagnostics Overview

Days Range

Low: ₹33.67
High: ₹35.45
Previous Close ₹35.44
Open ₹34.20
Volume 1,745
Day’s Range ₹33.67 - ₹35.45
52W Range ₹22.76 - ₹49.50
Market Cap ₹36.48 Cr

Fundamentals of Aspira Pathlab & Diagnostics

ROCE (TTM) NA
P/E Ratio (TTM) NA
P/B Ratio NA
Industry P/E NA
Debt to Equity NA
ROE NA
EPS (TTM) NA
Dividend Yield NA
Book Value NA
Face Value NA

Financials of Aspira Pathlab & Diagnostics

Financials data is not available for Aspira Pathlab & Diagnostics. Please visit after some time.

About Aspira Pathlab & Diagnostics

Aspira Pathlab & Diagnostics Limited is a public limited company incorporated in July 03rd, 1973. The Company is engaged into the business of running, owning, managing and administering Diagnostics Ce ... Read More

Parent Organisation Indian Private
Founded 1973
Managing Director Haseeb Drabu
NSE Symbol NA

Peer Comparison

Stocks Market Cap (cr) Market Price (₹) 52 Week Low-High (₹)
Aster DM Healthcare Ltd ₹16,251.66

330.7

4.85 (1.49%)

324.3 - 332.8
Opto Circuits (India) Ltd ₹53.51

1.8

0.00 (0.00)

1.8 - 1.85
Indraprastha Medical Corporation Ltd ₹1,460.30

161.1

1.45 (0.91%)

156.5 - 161.6
Krsnaa Diagnostics Ltd ₹2,042.73

650.25

2.35 (-0.36%)

640.9 - 657.45
Vijaya Diagnostic Centre Ltd ₹4,752.37

455.6

10.05 (-2.16%)

453 - 467.55

What's Trending

FAQs

What is the Share price of Aspira Pathlab & Diagnostics ()?

Aspira Pathlab & Diagnostics () share price as of September 22, 2023, on BSE is Rs 34.89 (BSE).

Can I buy Aspira Pathlab & Diagnostics () shares?

Yes, You can buy Aspira Pathlab & Diagnostics () shares by opening a Demat account with Angel One.

How do I buy Aspira Pathlab & Diagnostics () from Angel One?

Aspira Pathlab & Diagnostics () share can be brought through the following modes:
  1. Direct investment: You can buy Aspira Pathlab & Diagnostics () shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Aspira Pathlab & Diagnostics () shares.